Posted in | News | Signal Processing

Lockheed Martin Places Order for Northrop Grumman's APG-83 Scalable Agile Beam Radar

Less than four months after completing all design reviews, Northrop Grumman's APG-83 Scalable Agile Beam Radar (SABR) has received its first production order from Lockheed Martin.

Under the terms of the contract, Northrop Grumman will provide 142 radars to Lockheed Martin as part of the Taiwan Air Force F-16 upgrade program. The first production system will be delivered to Lockheed Martin in 2016.

"The maturity of SABR's design, coupled with our very experienced radar team, enabled us to bring all design reviews to a successful completion less than one year after contract award," said Jeff Leavitt, vice president, combat avionics systems business unit, Northrop Grumman. "The experience we have gained providing the radar for every F-16 in service, as well as for the F-22 and F-35, was invaluable in getting us to this point and will continue to guide us as we move toward production."

SABR is a multifunction, active electronically scanned array (AESA) fire control radar that brings fifth-generation air-to-air and air-to-ground radar capability to the F-16. It will give the F-16 pilots unprecedented situational awareness, targeting and intelligence, surveillance and reconnaissance capabilities.

AESA fire control radars developed by the company are currently flying on the F-16 Block 60, F-22 Raptor and F-35 Lightning II aircraft.

Northrop Grumman is a leading global security company providing innovative systems, products and solutions in unmanned systems, cyber, C4ISR, and logistics and modernization to government and commercial customers worldwide. Please visit www.northropgrumman.com for more information.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.